Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 11/01/2009

    What have sunscreens got to do with hormones?

    Most people are well aware that sunbathing can have dangerous consequences. In Switzerland the debate concerning the undesirable side effects of sunscreens has been temporarily put on hold but will most likely start up again with the onset of the winter season. Daniel R. Dietrich chair of the Department of Toxicology at the University of Constance gives us more details in the following interview.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-have-sunscreens-got-to-do-with-hormones
  • Press release - 21/09/2017

    Atriva reaches a development milestone and receives an additional tranche of running seed financing to develop its influenza therapeutic to clinical stage

    The next generation of Antiviral Therapies: Co-Led by Stichting Participatie Atriva and High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received a second tranche of its running seed financing in total of € 3 Mn from Dutch, German and Canadian investors, after lead compound ATR-002 (Atriva’s antiviral MEK-Inhibitor against Influenza) has passed an important preclinical milestone paving the way to clinical development stage.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/atriva-reaches-a-development-milestone-and-receives-an-additional-tranche-of-running-seed-financing-to-develop-its-influenza-the
  • Article - 10/09/2008

    Patients with rare diseases benefit from European research networks

    In some types of spinocerebellar ataxia and spastic paraplegia the number of people affected is so small that the search for the causes of the disease seems to be an almost hopeless endeavour. Human geneticist Prof. Dr. Olaf Rieß and neurologist Prof. Dr. Ludger Schöls from the University Hospital Tübingen are now hoping to promote research and improve the medical treatment of such patients with the aid of two new European networks.

    https://www.gesundheitsindustrie-bw.de/en/article/news/patients-with-rare-diseases-benefit-from-european-research-networks
  • Dossier - 02/05/2011 Corals (the photo shows an endoscopic image) appear to convert light for use by the algae.

    Molecular bionics – inspirations from the microworld for the macroworld

    Knowledge about the molecular organisation of structural and functional biological properties has led to the establishment of a new field of research molecular bionics. Everything that can be learnt from the macromolecular observation of interesting natural phenomena is complemented in this field by observations on the smallest i.e. molecular level. Processes and materials that have been optimised in the course of evolution are thus able to…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/molecular-bionics-inspirations-from-the-microworld-for-the-macroworld
  • Article - 29/11/2008

    Telomeres and stem cells - Building blocks associated with ageing

    Prof. Dr. Lenhard Rudolph a well-known stem cell researcher at Ulm University is investigating the relationships between telomeres stem cell ageing and diseases. In the following interview with Walter Pytlik BioRegion Ulm Rudolph gives insights into state-of-the-art ageing research and its potential applications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/telomeres-and-stem-cells-building-blocks-associated-with-ageing
  • Press release - 05/09/2011 12851_de.png

    Sequenom announces European licensing agreement with GATC daughter LifeCodexx

    Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/sequenom-announces-european-licensing-agreement-with-gatc-daughter-lifecodexx
  • Article - 18/10/2010 12708_de.jpg

    Abigail Morrison – How does the brain learn?

    The physicist and neuroscientist Prof. Dr. Abigail Morrison from the Bernstein Center for Computational Neuroscience BCCN in Freiburg has always been interested in theoretical questions relating to thinking and remembering. She now works on the development of computer models of different brain areas. Is it possible to untangle the complexities of neural networks in the brain using mathematics and informatics?

    https://www.gesundheitsindustrie-bw.de/en/article/news/abigail-morrison-how-does-the-brain-learn
  • Article - 13/02/2012 Photo of Dr. Suzanne Kadereit

    Suzanne Kadereit: assessing nanotoxicity using stem cells

    Nanotoxicity has become the subject of concern because of increasing toxic effects of nanomaterials on living organisms. However such effects are difficult to detect in people. In an interview with BIOPRO Baden-Württemberg Dr. Susanne Kadereit biologist at the University of Konstanz reports about her work involving the development of a human in-vitro system that enables the more effective assessment of the toxicity of nanoparticles.

    https://www.gesundheitsindustrie-bw.de/en/article/news/suzanne-kadereit-assessing-nanotoxicity-using-stem-cells
  • Press release - 28/08/2008

    Günther Schütz and the regulation of gene expression by nuclear receptors

    Professor Dr. Günther Schützs work on the cell- and development-specific gene regulation using nuclear receptors has led amongst other things to new insights into the steroid hormone-dependent early development and differentiation of the nervous system the molecular mechanisms of learning and the development and regulation of drug addiction. Schütz has now been appointed Helmholtz professor which will enable him to continue his work beyond…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guenther-schuetz-and-the-regulation-of-gene-expression-by-nuclear-receptors
  • Press release - 16/11/2015 BP-Branchenreport-2015-R-Web.jpg

    The Baden-Württemberg healthcare industry – a strong economic power

    (Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-baden-wuerttemberg-healthcare-industry-a-strong-economic-power
  • Expert interview on NTDs – part 1 - 11/04/2019 Carsten_Koehler_Profilbild_Tropenkrankheiten_Tuebingen.jpg

    Neglected tropical diseases – Carsten Köhler: impulses from Baden-Württemberg

    More than one billion people worldwide suffer from neglected tropical diseases (NTDs). NTDs are mostly poverty-related infectious diseases that prevail in tropical countries due to lack of research and measures to detect, prevent and control them. Dr. Dr. Carsten Köhler reports on the political, economic and scientific contributions Germany and Baden-Württemberg can make to successfully change this situation.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vernachlaessigte-tropenkrankheiten-carsten-koehler-impulse-aus-baden-wuerttemberg
  • Article - 03/10/2010 12509_de.jpg

    LimCo International - innovative methods to assess water pollution

    LimCo International has developed the Multispecies Freshwater Biomonitor a unique continuous early warning system that enables the fully automated detection of water contamination. The companys GamTox toxicity test can be used to assess the ecological situation of flowing waters.

    https://www.gesundheitsindustrie-bw.de/en/article/news/limco-international-innovative-methods-to-assess-water-pollution
  • Dossier - 14/06/2016 Schematic showing the defence chain of a prokaryote with CRISPR/Cas - integration of a phage genome into the CRISPR array and an infection of another phage whose genome is already "known" in the array. The new piece of DNA is immediately destroyed by the CRISPR/Cas complex.

    CRISPR/Cas – genome editing is becoming increasingly popular

    The number of publications and patents that involve the CRISPR/Cas system has been increasing exponentially since the technique was first described a few years ago. The increase in funding for projects involving CRISPR/Cas also demonstrates how powerful this new method is. The targeted modification of genomes (also called gene editing or genome editing) using CRISPR/Cas is extraordinarily accurate and also has the potential to cure hereditary…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/crisprcas-genome-editing-is-becoming-increasingly-popular
  • Article - 23/07/2012 The photo shows a group of five people standing in a row.

    The identification of stress molecules in living fish

    Fireflies use light to attract mates and hunt prey the zebrafish in Dr. Thomas Dickmeis laboratory mainly glow in situations of stress. The biologist from the Karlsruhe Institute of Technology KIT and two of his doctoral students have created a zebrafish line that can be used as a high-throughput test system for glucocorticoid hormones. Pharmaceutical companies might in future be able to use living vertebrate models i.e. zebrafish to test new…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-identification-of-stress-molecules-in-living-fish
  • Dossier - 07/02/2011 Picture shows a target, symbolising the vision of personalised medicine

    The era of personalised medicine is dawning

    A promising future does not easily disappear into thin air. This is certainly the case with the vision of personalised medicine. For many years, biomedical researchers have vaunted the potential benefits of their findings despite the fact that neutral observers do not think that personalised medicine will really take off within the next 15 or 20 years. Moreover personalised medicine is a controversial term. So what is the state of play right now?

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-era-of-personalised-medicine-is-dawning
  • Article - 02/09/2008

    Screening with high quality and high throughput

    The Early Discovery department of the research-based pharmaceutical company Nycomed GmbH deals with early drug research from the identification of targets to the generation of lead structures. This process involves high-throughput drug screening. On behalf of www.bio-pro.de Michael Statnik talked with Dr. Stefanie Polej about the process of the automated analysis of molecule activities in the Constance-based company.

    https://www.gesundheitsindustrie-bw.de/en/article/news/screening-with-high-quality-and-high-throughput
  • Dossier - 12/03/2012 16658_de.jpg

    Regenerative medicine makes use of patients’ own resources

    Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
  • Article - 25/01/2010 10570_de.jpg

    Treatment and Research Centre of Rare Diseases established in Tübingen

    On 22nd January 2010, the first German Treatment and Research Centre of Rare Diseases (ZSE) was officially opened in Tübingen. Interdisciplinary teams will from now on be developing new therapies under one roof for around three to four million patients suffering from rare diseases in Germany. The centre in Tübingen will offer optimal patient treatment, coordinate the cooperation between international specialists, and provide competent advice and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/treatment-and-research-centre-of-rare-diseases-established-in-tuebingen
  • Article - 15/12/2009 10405_de.jpg

    AppliedSensor GmbH – Chemical gas sensors to detect contaminants

    Sensors and sensor systems are the speciality of Reutlingen-based AppliedSensor GmbH. The company develops gas detectors for the detection of harmful inorganic and volatile organic compounds. The application of the detectors is as broad as the presence of such gases, and they can be used anywhere from small family houses to offices, from cattle sheds to cars.

    https://www.gesundheitsindustrie-bw.de/en/article/news/appliedsensor-gmbh-chemical-gas-sensors-to-detect-contaminants
  • Article - 04/07/2011 Schematic with several layers of different colour and structure.

    Gingiva grown in Petri dishes

    We use teeth to break down food and gum disease is the major cause of tooth loss. Our teeth are firmly anchored in the jaw bone and surrounded and supported by the gum (gingiva), one of the five types of tissue that make up the human periodontium. A complex interplay of biomolecules maintains homoeostasis, i.e. the natural balance, in the gum tissue. A team of researchers led by Prof. Dr. Pascal Tomakidi from the Freiburg University Medical…

    https://www.gesundheitsindustrie-bw.de/en/article/news/gingiva-grown-in-petri-dishes
  • Article - 29/05/2012 17282_de.jpg

    Isabelle Seemann: DNA as building block for nanostructures

    Since the emergence of nanotechnology in the 1980s DNA has been used as a construction material in many areas. Wires grids and nanorobots can all be produced from this versatile material. Isabelle Seemann scientist at the University of Konstanz works with a particular DNA constellation known as three-way DNA junction. Seemanns findings are of great importance for different areas of knowledge including the material sciences analytics and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/isabelle-seemann-dna-as-building-block-for-nanostructures
  • Article - 08/10/2012 18269_de.jpg

    The Heidelberg Institute of Human Genetics celebrates its 50th anniversary

    On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-heidelberg-institute-of-human-genetics-celebrates-its-50th-anniversary
  • Press release - 30/09/2008

    Harald Krug is investigating the use of new materials

    Prof. Dr. Harald Krug a toxicologist who runs the Materials-Biology Interaction division at Empa - Swiss Federal Laboratories for Materials Testing and Research in St. Gallen Switzerland and his team are investigating the interactions of synthetic materials with biological systems. The team of 25 researchers is focusing in particular on the effect of particles and nanomaterials such as CNT on human and animal cells. The division has been an…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-krug-is-investigating-the-use-of-new-materials
  • Article - 18/09/2011 The production of comparative spice materials consisting of homogeneously distributed allergenic raw materials is a must in the standardization, evaluation and optimization of allergen analytics. The major challenge is the homogeneous addition of smallest amounts (e.g. 1, 5, or 10 mg) of allergens to spice mixtures and the subsequent sensitive detection of these allergens.<br />

    BMBF project AllerGen: DNA test to protect consumers against food allergens

    People who are hypersensitive to a particular food protein can develop an adverse reaction to the smallest amount of the allergenic protein that can range from mild to severe. Although many allergic people are aware of their hypersensitivity to certain food proteins they can have allergic reactions because they are not always aware of the presence of allergenic proteins in certain food products. This is why the reliable sensitive and quantitative…

    https://www.gesundheitsindustrie-bw.de/en/article/news/bmbf-project-allergen-dna-test-to-protect-consumers-against-food-allergens
  • Article - 02/02/2015 Ulm: Biopharmaceutical production in stainless steel fermenters.

    Rentschler Biotechnologie invests in new production plant

    The Laupheim-based contract manufacturer Rentschler Biotechnologie GmbH is greatly expanding its production capacities. The company is investing €24 million in the construction of two 3,000 litre stainless steel bioreactors, which should be operational in early 2017 and will more than double the production capacities for cell culture-derived proteins. Rentschler also announced recently that it was adding a new 2,000 litre single-use bioreactor…

    https://www.gesundheitsindustrie-bw.de/en/article/news/rentschler-biotechnologie-invests-in-new-production-plant

Page 41 / 42

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search